Chiba University Hospital

Chiba, Chiba 260-8677

2 studies enrolling now · 17 studies all time

What they study most

ALS, Advanced Cholangiocarcinoma, Amyotrophic Lateral Sclerosis, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Bleeding, Dyslipidemia, FGFR2 Gene Rearrangements, Gastric Cancer, Gastroesophageal Junction Cancer, HER2+ Metastatic Breast Cancer (MBC), Heart Failure With Preserved Ejection Fraction (HFpEF)

Studies at this site

• ELEVATE-HFpEF Clinical Study — Recruiting now
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• CHAMPION-AF Clinical Trial — Running, not enrolling
• A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. — Stopped early
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Running, not enrolling
• Olorofim Aspergillus Infection Study — Running, not enrolling
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors — Completed
• Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements — Stopped early
• Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP — Completed
• An Efficacy and Safety Study of Ravulizumab in ALS Participants — Stopped early
• An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients — Completed
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed
• Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) — Completed
• A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study) — Stopped early
• Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma — Completed
• A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis — Completed